Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) booster vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsPrevent diphtheria, tetanus and pertussis; Prevent pertussis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today